🔴 HCW Biologics Inc is trading 12.3% down today on broad risk-off pressure in small-cap biotech

HCW Biologics Inc is trading 12.3% down at $1.43 in after-hours trading as macroeconomic headwinds continue to weigh on the small-cap biotech sector.

• The decline follows a regular-session sell-off in growth assets triggered by stronger-than-expected U.S. jobs data, which pressured high-risk equities.
• No company-specific news or regulatory filings appeared after the close, indicating the move is primarily driven by broader market sentiment.
• The stock previously closed the June 5 regular session flat at $1.63 before the current after-hours drop.